Zenas BioPharma (ZBIO) Other Non Operating Income (2023 - 2026)

Zenas BioPharma's Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$24000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 115.19% year-over-year to -$24000.0; the TTM figure through Mar 2026 stood at -$3.2 million (down 2720.54% YoY), while the FY2025 annual figure was $417000.0, up 106.44% from the prior year.
• Other Non Operating Income was -$24000.0 for Q1 2026 at Zenas BioPharma, up from -$7.2 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $3.0 million in Q2 2025 to a low of -$7.2 million in Q4 2025.
• Historically, Other Non Operating Income has averaged -$183818.2 across 4 years, with a median of $472000.0 in 2024.
• Biggest YoY gain for Other Non Operating Income was 14962.5% in 2024; the steepest drop was 670.62% in 2024.
• A 4-year view of Other Non Operating Income shows it stood at $793000.0 in 2023, then slumped by 670.62% to -$4.5 million in 2024, then sank by 58.59% to -$7.2 million in 2025, then surged by 99.67% to -$24000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$24000.0 (Q1 2026), -$7.2 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.